Horan Securities’s Novartis NVS Stock Holding History

Horan Securities’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-125	Closed	-$12.6K	–	465
2023 Q2	$12.6K	Hold	125	–	–	0.01%	362
2023 Q1	$11.5K	Sell	125 -5	-4%	-$437	0.01%	359
2022 Q4	$11.8K	Buy	130 +5	+4%	+$421	0.01%	354
2022 Q3	$10K	Sell	125 -54	-30%	-$4.48K	0.01%	354
2022 Q2	$15K	Buy	179 +54	+43%	+$4.74K	0.01%	283
2022 Q1	$11K	Hold	125	–	–	0.01%	315
2021 Q4	$11K	Buy	+125	New	+$10.4K	0.01%	314
2021 Q2	$11K	Hold	125	–	–	0.01%	294
2021 Q1	$11K	Hold	125	–	–	0.01%	262
2020 Q4	$12K	Hold	125	–	–	0.01%	239
2020 Q3	$11K	Sell	125 -48	-28%	-$4.16K	0.01%	207
2020 Q2	$15K	Buy	173 +48	+38%	+$4.14K	0.02%	147
2020 Q1	$10K	Buy	+125	New	+$11.2K	0.01%	133
2019 Q4	–	Sell	-125	Closed	-$11K	–	164
2019 Q3	$11K	Hold	125	–	–	0.01%	151
2019 Q2	$11K	Sell	125 -15	-11%	-$1.27K	0.01%	165
2019 Q1	$12K	Hold	140	–	–	0.01%	131
2018 Q4	$11K	Hold	140	–	–	0.01%	131
2018 Q3	$11K	Hold	140	–	–	0.01%	116
2018 Q2	$10K	Buy	+140	New	+$9.66K	0.01%	127

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Horan Securities's NVS Position: Q3 2023 in Review

Horan Securities sold out of Novartis (NVS) in Q3 2023, closing a stake of 125 shares — an estimated $12.6K sold.

Horan Securities first reported a position in NVS in Q2 2018 and held it in 19 quarters. The position peaked at $15K in Q2 2022. 1,223 funds tracked by Wall St. Rank hold NVS as of Q3 2023.

Horan Securities reported no remaining Novartis position as of Q3 2023 after selling out during the quarter.
Horan Securities sold 125 Novartis shares in Q3 2023, an estimated $12.6K.
Horan Securities first reported a position in Novartis in Q2 2018 and held it in 19 quarters.
Horan Securities's Novartis position peaked at $15K in Q2 2022.
1,223 funds tracked by Wall St. Rank held Novartis as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.